Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions.
HLA and pregnancy: the paradox of the fetal allograft.
How frequently should we follow small asymptomatic intracranial aneurysms?
Cardiac Rehabilitation
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9.
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9. Eur J Cancer. 2009 Jul; 45(11):1904-8.
View in:
PubMed
subject areas
Anticoagulants
Aryl Hydrocarbon Hydroxylases
Binding, Competitive
Cells, Cultured
Cytochrome P-450 CYP2C9
DNA Topoisomerases, Type II
DNA-Binding Proteins
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Interactions
Enzyme Inhibitors
Humans
Hydroxylation
International Normalized Ratio
Microsomes, Liver
Quinoxalines
Regression Analysis
Topoisomerase II Inhibitors
Warfarin
authors with profiles
Mark Ratain